Provider-Payer Convergence

by Hannah Ehnle | May 31, 2019

Chilmark’s Founder John Moore Answers: Why Research Health IT?

With Chilmark Research approaching 12 years old, I sat down with our founder, John Moore, to discuss why he chose to do research in the health IT industry as well as what inspired him to start his own analyst firm. (Answers have been edited for clarity and length.) Why did

by Matt Guldin | February 04, 2019

Webinar — Bundled Payments: Current Strategies and Tools

In this webinar, Chilmark Analyst Matt Guldin presents key findings from our report, Bundled Payments: Current Strategies and Tools. Afterward, he and special guest Andrew Tessier (Business Development Director, Signature Medical Group) discuss the financial and strategic implications of bundled payments and the IT options for providers. Key topics addressed: Market

by Matt Guldin | January 23, 2019

Walgreens ‘Front Door to Care’ Strategy is Building Horizontally

Key Takeaways: Walgreens ‘front door to care’ strategy is built around multiple horizontal partnerships. There are questions about how quickly these partnerships can scale to meet investors’ concerns and how Walgreens will monetize them. It is unclear how this new Microsoft partnership announcement fits in with the Walgreens digital consumer

by John Moore | January 21, 2019

Chilmark’s HIMSS’19 Recommended Sessions

Once again, it is that time of the year for our annual pilgrimage to HIMSS. While many attendees focus on the sheer size of the exhibit hall or packing their schedule full of meetings, we wanted to highlight the other major part of the event: education sessions. Below are this

by Chilmark Team | December 10, 2018

2019 Predictions: M&A, Big Tech, and the Fate of ACOs

The Meaningful Use gravy train finally came to an end in 2018. As the strongest EHR vendors struggle to define new revenue streams, weaker ones faded from view through acquisitions or leveraged buy-out. Meanwhile, funding for 'digital health' start-ups continued to increase, though it likely hit the high water mark

by Chilmark Team | November 29, 2018

Revisiting Our 2018 Predictions

As is our custom here, we like to look back on our predictions for the closing year and see just how well we did. Some years we do amazingly well, others we over-reach and miss on quite a few. For 2018, we got seven of our 13 predictions spot-on, two

by Matt Guldin | November 27, 2018

Is Radiation Oncology Ready for Alternative Payments?

Recent comments by Secretary Alex M. Azar II indicate changes ahead Chilmark recently released a report on the topic of bundles and enabling solutions. To learn more about this research, please click here. Key Takeaways Mandatory alternative payment model (APM) is coming for radiation oncologists. HHS has not yet released

by Chilmark Team | November 15, 2018

How Convergence Benefits Rising-Risk Patients

By Mark A. Caron, FACHE, CHCIO, Geneia CEO No matter how you look at it, the toll of diabetes and prediabetes is staggering whether you’re the patient, the primary care physician, the employer or the health plan. Nearly 30 million Americans have diabetes. People with diabetes are at increased risk of
View More >>

Stay up to the minute.

[bestwebsoft_contact_form]